Rituximab and ibrutinib in the treatment of Waldenstrom's macroglobulinemia

Erstveröffentlichung

2019

Authors

Grunenberg, Alexander

Buske, Christian

Wissenschaftlicher Artikel

Published in

Future Oncology ; 15 (2019), 23. - S. 2687-2697. - ISSN 1479-6694. - eISSN 1744-8301

Link to publication

https://dx.doi.org/10.2217/fon-2019-0154

Institutions

UKU. Institut für Experimentelle Tumorforschung
UKU. Klinik für Innere Medizin III

Subject headings

[Free subject headings]: CXCR4 | ibrutinib | MYD88 | rituximab | Waldenstrom's macroglobulinemia | L265P SOMATIC MUTATION | PHASE-II TRIAL | WEEKLY BORTEZOMIB | OPEN-LABEL | GENOMIC LANDSCAPE | TYROSINE KINASE | PRIMARY THERAPY | CLINICAL-TRIAL | DEXAMETHASONE
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record